These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 44693)

  • 41. Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone.
    Sokoloff P; Martres MP; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):89-102. PubMed ID: 7207647
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacological evidence for the subclassification of central dopamine receptors in the rat.
    Gower AJ; Marriott AS
    Br J Pharmacol; 1982 Sep; 77(1):185-93. PubMed ID: 6889902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of apomorphine and piribedil on pentylenetetrazol-induced seizures in mice.
    Riffee WH; Wilcox RE; Goldman CP; Smith RV
    Psychopharmacology (Berl); 1981; 75(4):391-5. PubMed ID: 6803286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Central effects of dopamine on vasopressin release in the normally hydrated and water-loaded rat.
    Forsling ML; Williams H
    J Physiol; 1984 Jan; 346():49-59. PubMed ID: 6699783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo.
    van Oene JC; de Vries JB; Horn AS
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):304-11. PubMed ID: 6514014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of daily dose of chronic haloperidol and chronic apomorphine on behavioral hypersensitivity in the rat.
    Kinon BJ; Merson D; Kane JM
    Psychopharmacology (Berl); 1984; 84(3):347-51. PubMed ID: 6440181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP.
    Hjorth S; Carlsson A; Clark D; Svensson K; Wikström H; Sanchez D; Lindberg P; Hacksell U; Arvidsson LE; Johansson A
    Psychopharmacology (Berl); 1983; 81(2):89-99. PubMed ID: 6415751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of the component enantiomers of the putative dopamine autoreceptor agonist, TL-99 (6,7-dihydroxy-2-dimethylamino tetralin) with dopaminergic systems in mammalian brain and teleost retina.
    Williams M; Martin GE; McClure DE; Baldwin JJ; Watling KJ
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):275-80. PubMed ID: 6141532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological characterization of the receptors involved in the apomorphine-induced polyphasic modifications of locomotor activity in mice.
    Protais P; Bonnet JJ; Costentin J
    Psychopharmacology (Berl); 1983; 81(2):126-34. PubMed ID: 6138794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine.
    Largent BL; Gundlach AL; Snyder SH
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4983-7. PubMed ID: 6087359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of dopamine autoreceptors in the postnatal rat brain.
    Hedner T; Lundborg P
    J Neural Transm; 1985; 62(1-2):53-63. PubMed ID: 3926953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats.
    Scalzo FM; Spear LP
    Psychopharmacology (Berl); 1985; 85(3):271-6. PubMed ID: 3923514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence.
    Clark D; Hjorth S; Carlsson A
    J Neural Transm; 1985; 62(1-2):1-52. PubMed ID: 3894582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of acute and chronic treatment with an atypical antidepressant drug, nomifensine, on the sleep-wake activity in rats.
    Lelkes Z; Obál F; Benedek G; Rubicsek G; Alföldi P; Obál F
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):149-53. PubMed ID: 3561528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discriminative stimulus effects of a low dose of apomorphine in the rat.
    Tang AH; Franklin SR
    Psychopharmacology (Berl); 1987; 91(1):61-6. PubMed ID: 3103160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative study of sulpiride and haloperidol on dopamine turnover in the rat brain.
    Imazu Y; Kobayashi K; Shohmori T
    Neurochem Res; 1989 May; 14(5):459-64. PubMed ID: 2747836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Possible existence of a presynaptic positive feedback mechanism enhancing dopamine transmission in the anterior cingulate cortex of the rat.
    Beauregard M; Ferron A; Descarries L
    Experientia; 1989 Sep; 45(9):888-92. PubMed ID: 2570715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies on the discriminative stimulus properties of apomorphine in rhesus monkeys.
    Tang AH; Code RA
    Psychopharmacology (Berl); 1989; 97(3):418-22. PubMed ID: 2497493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection.
    Fuxe K; Janson AM; Jansson A; Andersson K; Eneroth P; Agnati LF
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):171-81. PubMed ID: 2342600
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of cholecystokinin receptors in the control of striatal dopamine autoreceptors.
    Tanganelli S; Fuxe K; von Euler G; Agnati LF; Ferraro L; Ungerstedt U
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):300-4. PubMed ID: 2280797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.